Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hubei LuJinZi Pharmaceutical Co., Ltd. is a specialized modern pharmaceutical company based in Ezhou, Hubei Province, China. As a key enterprise of the Wuchangyu Group, the company integrates biopharmaceuticals, drug research and development, and sales. Its product portfolio spans seven major series, including tablets, capsules, granules, syrups, biochemical raw materials, health foods, and medical devices, with nearly a hundred varieties. The company is particularly known for its biochemical preparations, which account for 40% of its products, featuring key offerings such as pepsin, pancreatin, gastric mucin, chondroitin sulfate, and velase, alongside traditional Chinese medicines like Tongfushu tablets for gout.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hubei Lǜvjinzi Pharmaceutical.